152 related articles for article (PubMed ID: 23749161)
1. Eudragit® L100/N-trimethylchitosan chloride microspheres for oral insulin delivery.
Marais E; Hamman J; Plessis Ld; Lemmer R; Steenekamp J
Molecules; 2013 Jun; 18(6):6734-47. PubMed ID: 23749161
[TBL] [Abstract][Full Text] [Related]
2. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
3. Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies.
Jain D; Majumdar DK; Panda AK
J Biomater Appl; 2006 Oct; 21(2):195-211. PubMed ID: 16443624
[TBL] [Abstract][Full Text] [Related]
4. pH-Sensitive oral insulin delivery systems using Eudragit microspheres.
Mundargi RC; Rangaswamy V; Aminabhavi TM
Drug Dev Ind Pharm; 2011 Aug; 37(8):977-85. PubMed ID: 21417605
[TBL] [Abstract][Full Text] [Related]
5. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
7. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
9. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.
Anande NM; Jain SK; Jain NK
Int J Pharm; 2008 Jul; 359(1-2):182-9. PubMed ID: 18486369
[TBL] [Abstract][Full Text] [Related]
10. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
11. Eudragit S100 entrapped insulin microspheres for oral delivery.
Jain D; Panda AK; Majumdar DK
AAPS PharmSciTech; 2005 Sep; 6(1):E100-7. PubMed ID: 16353953
[TBL] [Abstract][Full Text] [Related]
12. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
Rawat M; Saraf S; Saraf S
AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
[TBL] [Abstract][Full Text] [Related]
13. Enteric microsphere formulations of papain for oral delivery.
Sharma M; Sharma V; Panda AK; Majumdar DK
Yakugaku Zasshi; 2011; 131(5):697-709. PubMed ID: 21532266
[TBL] [Abstract][Full Text] [Related]
14. Preparation and sustained release of diatomite incorporated and Eudragit L100 coated hydroxypropyl cellulose/chitosan aerogel microspheres.
Sang Y; Gao J; Han X; Liang T; Chen T; Zhao Y
Int J Biol Macromol; 2024 May; 267(Pt 1):131447. PubMed ID: 38588843
[TBL] [Abstract][Full Text] [Related]
15. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
16. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
Malipeddi VR; Dua K; Awasthi R
Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
[TBL] [Abstract][Full Text] [Related]
19. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
20. Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology.
Agrawal G; Wakte P; Shelke S
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):149-165. PubMed ID: 28472911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
